Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Castellani, Rudolph J.a; * | Shanes, Elisheva D.a | McCord, Matthewa | Reish, Nicholas J.c | Flanagan, Margaret E.b | Mesulam, M-Marselc; d | Jamshidi, Pouyaa
Affiliations: [a] Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA | [b] Department of Pathology, University of Texas, San Antonio, San Antonio, TX, USA | [c] Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA | [d] Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Correspondence: [*] Correspondence to: Rudolph J. Castellani, MD, 710 N Fairbanks Court, Olson Pavilion 2-514, Chicago, IL 60611, USA. Tel.: +1 312 694 6852; Fax: +1 312 926 9830; E-mail:[email protected].
Abstract: Host responses to anti-amyloid-β (Aβ) antibody therapy are evident in neuroimaging changes and clinical symptoms in a subset of clinical trial subjects receiving such therapy. The pathological basis for the imaging changes and clinical symptoms is not known, nor is the precise mechanism of Aβ clearing. We report the autopsy findings in a 65-year-old woman who received three open label infusions of the experimental anti-Aβ drug lecanemab over about one month. Four days after the last infusion, she was treated with tissue plasminogen activator for acute stroke symptoms and died several days later with multifocal hemorrhage. Neuropathological examination demonstrated histiocytic vasculitis involving blood vessels with cerebral amyloid angiopathy. Fragmentation and phagocytosis of vascular Aβ were present throughout the cerebral cortex. Phagocytosis of parenchymal Aβ plaques was noted. Changes suggestive of Aβ and phosphorylated tau “clearing” were also noted. The findings overall suggest that anti-Aβ treatment stimulated a host response to Aβ, i.e., target engagement. The findings also provide evidence that amyloid-related imaging abnormalities might be indicative of an Aβ phagocytic syndrome within cerebral vasculature and parenchymal brain tissue in some cases.
Keywords: Alzheimer’s disease, amyloid-β , amyloid-related imaging abnormalities, Apolipoprotein E, cerebral amyloid angiopathy, hemorrhage, lecanemab, phosphorylated tau, vasculitis
DOI: 10.3233/JAD-221305
Journal: Journal of Alzheimer's Disease, vol. 93, no. 2, pp. 803-813, 2023
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]